Compare Multiple Daily Injections With Carbohydrate Counting or With Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes

Exclusion Criteria

• •1. Serious medical illness likely to interfere with study participation or with the ability to complete the trial by the judgment of the investigator.
• •2. Failure to comply with the study protocol or with team's recommendations.
• •3. Injection of isophane insulin (NPH) or any intermediate-acting insulin.
• •4. More than 1 slow-acting injection and unwilling to switch to once a day for the study
• •5. Current or ≤ 1 month use of other antihyperglycemic agents (SGLT2, GLP-1, Metformin, Acarbose, etc.).
• •6. Pregnancy.
• •7. Severe hypoglycemic episode within one month of admission.
• •8. Severe diabetic ketoacidosis episode within one month of admission.
• •9. Clinically significant nephropathy, neuropathy, or retinopathy as judged by the investigator.
• •10. Conditions that may interfere with accurate HbA1c levels: clinically significant anemia, hemoglobinopathy, or a recent blood transfusion as judged by the investigator.